{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:12:15Z","timestamp":1791335535980,"version":"4.3.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2003,6,1]],"date-time":"2003-06-01T00:00:00Z","timestamp":1054425600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2003,6,1]],"date-time":"2003-06-01T00:00:00Z","timestamp":1054425600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2003,6]]},"DOI":"10.1023\/a:1025700807451","type":"journal-article","created":{"date-parts":[[2003,10,24]],"date-time":"2003-10-24T14:33:40Z","timestamp":1067006020000},"page":"73-78","source":"Crossref","is-referenced-by-count":54,"title":["Histopathological characteristics of BRCA1- and BRCA2-associated intraperitoneal cancer: a clinic-based study"],"prefix":"10.1007","volume":"2","author":[{"given":"Jurgen M. J.","family":"Piek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bas","family":"Torrenga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda","family":"Hermsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9 H. M.","family":"Verheijen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald P.","family":"Zweemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan J. P.","family":"Gille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kenemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"van Diest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred H.","family":"Menko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"issue":"3","key":"5142097_CR1","first-page":"177","volume":"1242","author":"J Feunteun","year":"1996","unstructured":"Feunteun J, Lenoir GM. BRCA1, a gene involved in inherited predisposition to breast and ovarian cancer. Biochim Biophys Acta 1996; 1242(3): 177\u201380.","journal-title":"Biochim Biophys Acta"},{"key":"5142097_CR2","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1006\/gyno.1999.5623","volume":"76","author":"RP Zweemer","year":"2000","unstructured":"Zweemer RP, van Diest PJ, Verheijen RH et al. Molecular evidence linking primary cancer of the fallopian tube to BRCA1 germline mutations. Gynecol Oncol 2000; 76: 45\u201350.","journal-title":"Gynecol Oncol"},{"key":"5142097_CR3","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/S0029-7844(98)00223-3","volume":"92","author":"CA Bandera","year":"1998","unstructured":"Bandera CA, Muto MG, Schorge JO et al. BRCA1 gene mutations in women with papillary serous carcinoma of the peritoneum. Obstet Gynecol 1998; 92: 596\u2013600.","journal-title":"Obstet Gynecol"},{"issue":"11","key":"5142097_CR4","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1093\/jnci\/90.11.841","volume":"90","author":"JO Schorge","year":"1998","unstructured":"Schorge JO, Muto MG, Welch WR et al. Molecular evidence for multifocal papillary serous carcinoma of the peritoneum in patients with germline BRCA1 mutations. J Natl Cancer Inst 1998; 90(11): 841\u20135.","journal-title":"J Natl Cancer Inst"},{"issue":"19","key":"5142097_CR5","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1056\/NEJM199611073351901","volume":"335","author":"SC Rubin","year":"1996","unstructured":"Rubin SC, Benjamin I, Behbakht K et al. Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1. N Engl J Med 1996; 335(19): 1413\u20136.","journal-title":"N Engl J Med"},{"issue":"17","key":"5142097_CR6","first-page":"1255","volume":"336","author":"O Johannsson","year":"1997","unstructured":"Johannsson O, Ranstam J, Borg A, Olsson H. BRCA1 mutations and survival in women with ovarian cancer. N Engl J Med 1997; 336(17): 1255\u20136.","journal-title":"N Engl J Med"},{"key":"5142097_CR7","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1056\/NEJM199704173361602","volume":"336","author":"JF Stratton","year":"1997","unstructured":"Stratton JF, Gayther SA, Russell P et al. Contribution of BRCA1 mutations to ovarian cancer. N Engl J Med 1997; 336: 1125\u201330.","journal-title":"N Engl J Med"},{"issue":"17","key":"5142097_CR8","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1001\/jama.283.17.2260","volume":"283","author":"J Boyd","year":"2000","unstructured":"Boyd J, Sonoda Y, Federici MG et al. Clinicopathologic features of BRCA-linked and sporadic ovarian cancer. JAMA 2000; 283(17): 2260\u20135.","journal-title":"JAMA"},{"issue":"2","key":"5142097_CR9","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0301-2115(98)00218-8","volume":"82","author":"RP Zweemer","year":"1999","unstructured":"Zweemer RP, Verheijen RH, Menko FH et al. Differences between hereditary and sporadic ovarian cancer. Eur J Obstet Gynecol Reprod Biol 1999; 82(2): 151\u20133.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"5142097_CR10","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1086\/318787","volume":"86","author":"HA Risch","year":"2001","unstructured":"Risch HA, McLaughlin JR, Cole DEC et al. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am J Hum Genet 2001; 86: 700\u201310.","journal-title":"Am J Hum Genet"},{"issue":"4","key":"5142097_CR11","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1097\/00004347-200210000-00011","volume":"21","author":"PA Shaw","year":"2002","unstructured":"Shaw PA, McLaughlin JR, Zweemer RP et al. Histopathologic features of genetically determined ovarian cancer. Int J Gynecol Pathol 2002; 21(4): 407\u201311.","journal-title":"Int J Gynecol Pathol"},{"issue":"1","key":"5142097_CR12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1006\/gyno.2001.6465","volume":"85","author":"MS. Piver","year":"2002","unstructured":"Piver MS. Hereditary ovarian cancer. Lessons from the first twenty years of the Gilda Radner Familial Ovarian Cancer Registry. Gynecol Oncol 2002; 85(1): 9\u201317.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"5142097_CR13","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/humu.10090","volume":"20","author":"H Yazici","year":"2002","unstructured":"Yazici H, Glendon G, Yazici H et al. BRCA1 and BRCA2 mutations in Turkish familial and non-familial ovarian cancer patients: a high incidence of mutations in non-familial cases. Hum Mutat 2002; 20(1): 28\u201334.","journal-title":"Hum Mutat"},{"key":"5142097_CR14","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/S0002-9378(98)70632-5","volume":"178","author":"RP Zweemer","year":"1998","unstructured":"Zweemer RP, Verheijen RH, Gille JJ et al. Clinical and genetic evaluation of thirty ovarian cancer families. Am J Obstet Gynecol 1998; 178: 85\u201390.","journal-title":"Am J Obstet Gynecol"},{"key":"5142097_CR15","first-page":"1","volume-title":"Gynaecological Tumours in The Netherlands","year":"1997","unstructured":"Visser O, Coebergh JW, Otter R (eds). Gynaecological Tumours in The Netherlands. Association of Comprehensive Cancer Centers Utrecht. Almelo, The Netherlands: Lulof, 1997: 1\u201326."},{"issue":"11","key":"5142097_CR16","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1016\/S0046-8177(00)80014-3","volume":"31","author":"BA Werness","year":"2000","unstructured":"Werness BA, Ramus SJ, Whittemore AS et al. Histopathology of familial ovarian tumors in women from families with and without germline BRCA1 mutations. Hum Pathol 2000; 31(11): 1420\u20134.","journal-title":"Hum Pathol"},{"issue":"2","key":"5142097_CR17","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0301-2115(00)00521-2","volume":"97","author":"B Piura","year":"2001","unstructured":"Piura B, Rabinovich A, Yanai-Inbar I. Three primary malignancies related to BRCA mutation successively occurring in a BRCA1 185delAG mutation carrier. Eur J Obstet Gynecol Reprod Biol 2001; 97(2): 241\u20134.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"4","key":"5142097_CR18","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/path.1000","volume":"195","author":"JM Piek","year":"2001","unstructured":"Piek JM, van Diest PJ, Zweemer RP et al. Dysplastic changes in prophylactically removed fallopian tubes of women predisposed to developing ovarian cancer. J Pathol 2001; 195(4): 451\u20136.","journal-title":"J Pathol"},{"issue":"2","key":"5142097_CR19","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1097\/00000478-200202000-00003","volume":"26","author":"SN Agoff","year":"2002","unstructured":"Agoff SN, Mendelin JE, Grieco VS, Garcia RL. Unexpected gynecologic neoplasms in patients with proven or suspected BRCA-1 or-2 mutations: implications for gross examination, cytology, and clinical follow-up. Am J Surg Pathol 2002; 26(2): 171\u20138.","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"5142097_CR20","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1046\/j.1525-1438.1994.04060384.x","volume":"4","author":"R Woolas","year":"1994","unstructured":"Woolas R, Jacobs I, Prys Davies A et al. What is the true incidence of fallopian tube carcinoma? Int J Gynecol Cancer 1994; 4(6): 384\u20138","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"5142097_CR21","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1097\/00004347-200304000-00001","volume":"22","author":"TJ. Colgan","year":"2003","unstructured":"Colgan TJ. Challenges in the early diagnosis and staging of fallopian-tube carcinomas associated with BRCA mutations. Int J Gynecol Pathol 2003; 22(2): 109\u201320.","journal-title":"Int J Gynecol Pathol"},{"key":"5142097_CR22","unstructured":"Eeles R, Piver S, Piek JM et al. Inherited tumour syndromes. In Tavasolli F, Devilee P (eds), WHO Classification of Gynaecological Tumours. Lyon: IARC Press (in press)."},{"key":"5142097_CR23","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/0002-9378(50)90341-3","volume":"59","author":"CY Hu","year":"1950","unstructured":"Hu CY, Taymor ML, Hertig AT. Primary carcinoma of the fallopian tube. Am J Obstet Gynecol 1950; 59: 58.","journal-title":"Am J Obstet Gynecol"},{"key":"5142097_CR24","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1046\/j.1525-1438.1997.00455.x","volume":"7","author":"R Woolas","year":"1997","unstructured":"Woolas R, Smith J, Paterson JM, Sharp F. Fallopian tube carcinoma: an under-recognized primary neoplasm. Int J Gynecol Cancer 1997; 7: 284\u20138.","journal-title":"Int J Gynecol Cancer"},{"issue":"9284","key":"5142097_CR25","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/S0140-6736(01)05992-X","volume":"358","author":"JM Piek","year":"2001","unstructured":"Piek JM, van Diest PJ, Zweemer RP et al. Tubal ligation and risk of ovarian cancer. Lancet 2001; 358(9284): 844\u20135.","journal-title":"Lancet"},{"key":"5142097_CR26","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1023\/A:1023265919884","volume":"2","author":"S Levene","year":"2003","unstructured":"Levene S, Scott G, Price P et al. Does the occurrence of certa in rare cancers indicate an inherited cancer susceptibility? Familial Cancer 2003; 2: 15\u201325.","journal-title":"Familial Cancer"},{"issue":"5","key":"5142097_CR27","first-page":"1361","volume":"60","author":"JO Schorge","year":"2000","unstructured":"Schorge JO, Muto MG, Lee SJ et al. BRCA1-related papillary serous carcinoma of the peritoneum has a unique molecular pathogenesis. Cancer Res 2000; 60(5): 1361\u20134.","journal-title":"Cancer Res"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1025700807451.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1025700807451\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1025700807451.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T04:52:50Z","timestamp":1754369570000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1025700807451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,6]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2003,6]]}},"alternative-id":["5142097"],"URL":"https:\/\/doi.org\/10.1023\/a:1025700807451","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"value":"1389-9600","type":"print"},{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,6]]}}}